US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Sensus Healthcare, Inc. - Common Stock (NQ:SRTS)

2.980 +0.030 (+1.02%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sensus Healthcare, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Sensus (SRTS) Q2 2026 Earnings Call Transcript ↗
Financing delays crushed Q2 revenue, but management expects recovery in Q3. 
Via The Motley Fool
Topics Earnings
News headline image
Sensus Healthcare Q2 Earnings Call Highlights ↗
Sensus Healthcare (NASDAQ:SRTS) reported second-quarter revenue of $2.3 million, down from $7.3 million a year earlier, as delayed third-party financing prevented the company from recognizing revenue... 
Via MarketBeat
Topics Earnings
News headline image
Full Transcript: Sensus Healthcare Q2 2026 Earnings Call ↗
Sensus Healthcare (NASDAQ:SRTS) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For... 
Via Benzinga
Topics Earnings
News headline image
Sensus Healthcare Reports Second Quarter 2026 Financial Results and Business Highlights
From Sensus Healthcare, Inc.
Via Business Wire
Sensus Healthcare Inc (NASDAQ:SRTS) Misses Q1 Estimates as Revenue Drops, But New CPT Codes Provide a Tailwind ↗
Via Chartmill
Sensus Healthcare Inc (NASDAQ:SRTS) Stock Plummets After Q4 Earnings and Revenue Miss ↗
Via Chartmill
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Q1 Earnings Call Highlights ↗
Sensus Healthcare (NASDAQ:SRTS) said its first quarter of 2026 marked a transition period as new dedicated CPT codes for superficial radiotherapy took effect, while revenue declined from the prior year... 
Via MarketBeat
Topics Earnings
News headline image
Sensus (SRTS) Q1 2026 Earnings Transcript ↗
Sensus (SRTS) Q1 2026 Earnings Transcript 
Via The Motley Fool
News headline image
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare to Report First Quarter 2026 Financial Results and Hold Business Update Conference Call on May 7, 2026
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare SRTS Q4 2025 Earnings Transcript ↗
Sensus Healthcare SRTS Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare to Report Fourth Quarter and Full Year 2025 Financial Results and Hold Business Update Conference Call on February 12, 2026
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare to Hold Investor Meetings During JPM Week 2026 in San Francisco
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Appoints Larry Biscotti to its Board of Directors
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Expands Role of President Michael Sardano to Include Chief Commercial Officer
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Appoints Eric Sachetta to its Board of Directors
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus SRTS Q3 2025 Earnings Call Transcript ↗
Sensus SRTS Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Sensus Healthcare Inc (NASDAQ:SRTS) Beats Q3 2025 Earnings Estimates Despite Revenue Decline ↗
Sensus Healthcare (SRTS) beat Q3 2025 earnings estimates despite a revenue dip. The company highlighted a key regulatory win with new CPT codes for its skin cancer treatment technology. 
Via Chartmill
News headline image
Sensus Healthcare Reports Third Quarter 2025 Financial Results
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Named to TIME’s America’s Growth Leaders of 2026
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
CMS Establishes Coding Validating Sensus SRT for Treating Non-Melanoma Skin Cancer
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare Announces the Passing of Director Bill McCall
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6
From Sensus Healthcare, Inc.
Via Business Wire
News headline image
SENSUS INVESTIGATION REMINDER: Bragar Eagel & Squire, Reminds Sensus Healthcare Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Sensus Stockholders
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 Next >